Missouri · A9584

Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in Missouri

Missouri Medicare Avg
$2,136.15
3% above national avg
National Medicare Avg
$2,070.16
All states combined
Billed Charge (MO)
$3,750.00
What providers submit
Est. Commercial (MO)
$5,576.65
National avg: $5,823.38
Est. Cash / Self-Pay (MO)
$3,042.06
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

31
Services in MO
1
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Missouri

Provider Medicare Services
Mousa, Mina MD $2,136.15 31

Missouri Pricing in Context

In Missouri, CPT code A9584 (Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries) carries an average Medicare payment of $2,136.15 — 3% above the national benchmark of $2,070.16. 1 providers across the state submitted claims for this procedure in 2023, performing 31 total services. Individual payments in MO ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Missouri is $3,750.00, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Missouri sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Missouri lands near $5,576.65, with self-pay cash prices typically around $3,042.06. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cost in Missouri?

The average Medicare payment for Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in Missouri is $2,136.15, which is 3% above the national average of $2,070.16. Providers in MO typically bill $3,750.00 for this procedure.

What does Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cost with insurance in Missouri?

With commercial insurance in Missouri, Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries costs an estimated $5,576.65. Without insurance, the estimated cash price is $3,042.06. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in Missouri?

1 providers in Missouri billed Medicare for Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries in 2023, performing 31 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries cheaper in Missouri than the national average?

No — Iodine 1-123 Ioflupane, Diagnostic, Per Study Dose, Up To 5 Millicuries costs 3% above the national average in Missouri. The state average Medicare payment is $2,136.15 compared to $2,070.16 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial